Error: Could not add to watchlist. X

Exelixis Inc

+ Watchlist
EXEL:US
NASDAQ GS
6.62
USD
0.50
8.17%
As of 17:20:00 ET on 08/04/2015.
Open
6.25
Day Range
6.25 - 6.67
Volume
14,557,618
Previous Close
6.12
52Wk Range
1.26 - 6.67
1 Yr Return
61.07%
Open
6.25
Day Range
6.25 - 6.67
Volume
14,557,618
Previous Close
6.12
52Wk Range
1.26 - 6.67
1 Yr Return
61.07%
YTD Return
359.72%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-1.15
Market Cap (b USD)
1.468
Shares Outstanding (m)
221.021
Price/Sales (TTM)
43.72
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
Profile
Exelixis, Inc. is a development-stage biotechnology company dedicated to the discovery and development of small-molecule therapeutics for the treatment of cancer and other serious diseases. The Company is building a portfolio of compounds it believes could become pharmaceutical products. Exelixis has strategic alliances with pharmaceutical and biotechnology companies.
ADDRESS
210 East Grand Avenue
PO Box 511
South San Francisco, CA 94083-0511
United States
PHONE
1-650-837-7000
  • Michael M Morrissey
    President/CEO
  • Christopher J Senner
    Exec VP/CFO
  • Jeffrey J Hessekiel
    Exec VP/Secy/General Counsel
  • Peter Lamb
    Exec VP:Discovery Research
  • Gisela M Schwab
    Exec VP/Chief Medical Officer
Show More